Search company, investor...

Founded Year



Private Equity | Alive

Total Raised




Last Raised

$250M | 3 yrs ago



About Pharmapacks

Pharmapacks operates as an e-commerce growth and enablement company. It offers services in sales management, marketing, fulfillment, and logistics to help brands increase their sales on digital marketplaces. The company serves the e-commerce industry. It was founded in 2010 and is based in Islandia, New York.

Headquarters Location

1516 Motor Parkway

Islandia, New York, 11749,

United States




Research containing Pharmapacks

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Pharmapacks in 1 CB Insights research brief, most recently on Aug 3, 2021.

Expert Collections containing Pharmapacks

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Pharmapacks is included in 3 Expert Collections, including E-Commerce.



10,697 items

Companies that sell goods online (B2C), or enable the selling of goods online via tech solutions (B2B).


Unicorns- Billion Dollar Startups

1,229 items


Digital Health

10,804 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.

Latest Pharmapacks News

BFS (Blow-Fill-Seal) Product Market Revolutionary Trends in Industry Growth Statistics By 2030

Jul 5, 2023

News Provided By Share This Article Reports And Data BFS technology finds applications in the cosmetics and personal care industry, as well as the Food & Beverage (F&B) sector and other industries. NEW YORK CITY, U.S., UNITED STATES, July 5, 2023/ / -- The global Blow-Fill-Seal (BFS) products market size to reached USD 374.4 Million in 2021 and is projected to experience a compound annual growth rate (CAGR) of 5.9% throughout the forecast period. The market's revenue growth is primarily attributed to the rapid advancement of BFS technology and the increasing adoption of BFS products, such as bottles, vials, and others, in pharmaceutical companies. BFS technology is utilized to manufacture BFS products, offering a swift, accurate, safe, and energy-efficient method for pharmaceutical filling. These products are often recyclable and possess greater durability compared to glass. The machinery used in this process can create various shapes based on the specific requirements of end customers. As BFS technology ensures contamination-free packaging and expedites processing, it has become the preferred choice for pharmaceutical companies. The primary products manufactured using BFS technology include bottles, ampoules, vials, pre-filled syringes, and others, which are used for filling medications, vaccines, ophthalmology, respiratory treatments, injectable biopharmaceuticals, wound care, and biologics. Get Free Sample PDF (To Understand the Complete Structure of this Report [Summary + TOC]) @ BFS (Blow-Fill-Seal) Product Market Segments: The global Blow-Fill-Seal (BFS) product market is projected to witness substantial growth in the coming years, with a market size of USD 374.4 million in 2021. It is expected to achieve a CAGR of 5.9% from 2021 to 2030, reaching a revenue forecast of USD 627.4 million by 2030. The estimation is based on historical data from 2019 to 2020 and takes into account the market dynamics during the forecast period from 2022 to 2030. The quantitative units used for measurement are in USD million. The report covers various aspects of the market, including revenue forecast, company ranking, competitive landscape, growth factors, and trends. It analyzes the market based on different parameters such as Type Outlook, Product Outlook, Application Outlook, and Regional Outlook. In terms of types, the market is segmented into High-Density Polyethylene, Ethylene Vinyl Alcohol (EVOH), Polypropylene (PP), and Low-Density Polyethylene (LDPE). These different types of materials are utilized in the production of BFS products. The product outlook segment includes bottles, ampoules, vials, pre-filled syringes, and other BFS products. These products find applications in various industries such as pharmaceuticals, food & beverages, cosmetic & personal care, and others. The market's regional scope covers North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. These regions are key players in the BFS product market and contribute to its overall growth. With increasing demand for efficient and contamination-free packaging solutions, along with technological advancements in BFS technology, the market is poised for significant expansion in the forecast period. Inquiry Before Buying: BFS (Blow-Fill-Seal) Product Market Competitive landscape: The global BFS (Blow-Fill-Seal) product market is characterized by a moderately consolidated competitive landscape, with a few major companies operating at both global and regional levels. These key players in the market are actively involved in various strategies such as product development and strategic alliances to enhance their product portfolios and establish a strong presence in the global market. Among the prominent companies operating in the BFS product market, Catalent, Inc. stands out as a major player. Catalent is engaged in the development of advanced BFS solutions and has a significant global reach. Their focus on innovation and technological advancements has enabled them to expand their product offerings and maintain a competitive edge. Recipharm AB is another notable company in the market. They specialize in contract manufacturing and development of BFS products. With their expertise in pharmaceutical solutions, Recipharm has successfully established a strong position in the global BFS market. Through strategic partnerships and collaborations, they continue to expand their product portfolio and cater to the evolving needs of their clients. SALVAT, The Ritedose Corporation, BirgiMefar, Unicep, and Pharmapacks are also recognized as major players in the BFS product market. These companies have made significant investments in research and development to introduce innovative and high-quality BFS products. By focusing on customer satisfaction and providing customized solutions, they have gained a loyal customer base and a competitive advantage in the market. Additionally, Unolab Manufacturing SL, Merck & Co., Inc., Weiler Engineering, Inc., Curida, and Horizon Therapeutics plc are contributing to the competitive landscape of the BFS product market. These companies are actively involved in manufacturing and delivering a wide range of BFS products, catering to diverse sectors such as pharmaceuticals, healthcare, and cosmetics. Through continuous investments in research and development, they aim to expand their market presence and stay ahead in the competitive market. In conclusion, the global BFS product market is moderately consolidated, with major companies like Catalent, Inc., Recipharm AB, SALVAT, The Ritedose Corporation, BirgiMefar, Unicep, Pharmapacks, Unolab Manufacturing SL, Merck & Co., Inc., Weiler Engineering, Inc., Curida, and Horizon Therapeutics plc driving the market growth through product development and strategic alliances. These companies continue to innovate and expand their offerings to meet the evolving demands of the global market, positioning themselves as leaders in the BFS industry. Browse More Reports: Coalescing Agent Market: About Us: Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors. John W.

Pharmapacks Frequently Asked Questions (FAQ)

  • When was Pharmapacks founded?

    Pharmapacks was founded in 2010.

  • Where is Pharmapacks's headquarters?

    Pharmapacks's headquarters is located at 1516 Motor Parkway, Islandia.

  • What is Pharmapacks's latest funding round?

    Pharmapacks's latest funding round is Private Equity.

  • How much did Pharmapacks raise?

    Pharmapacks raised a total of $476M.

  • Who are the investors of Pharmapacks?

    Investors of Pharmapacks include Carlyle, Reckitt Benckiser, The Emerson Group, The Craftory, Stratus Group and 7 more.



CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.